Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Christophe, Cans"'
Autor:
Isabelle Diaz, Béatrice Augendre-Ferrante, Christophe Cans, Dominique Cellier, Gilles Paintaud, Denis Mulleman, Jean-Michel Joubert, Marie-Pierre Chevalier, Rémi Urbain, Jacques-Eric Gottenberg, Jamila Filipecki, Johan Le Men, Jean-Emmanuel Kahn, Daniel Vasmant
Publikováno v:
Therapies. 69:297-302
Despite very different aetiologies and clinical expressions, advancing knowledge in the physiopathology and treatment of immune and inflammatory diseases (IID) prompts us to consider them as a whole. These are chronic, often incapacitating and painfu
Autor:
Jamila Filipecki, Jean-Emmanuel Kahn, Jean-Michel Joubert, Denis Mulleman, Rémi Urbain, Isabelle Diaz, Christophe Cans, Béatrice Augendre-Ferrante, Gilles Paintaud, Dominique Cellier, Johan Le Men, Marie-Pierre Chevalier, Jacques-Eric Gottenberg, Daniel Vasmant
Publikováno v:
Therapies. 69:291-296
Resume Malgre des etiologies et expressions cliniques tres diverses, la progression des connaissances dans les domaines de laphysiopathologie et de la therapeutique des pathologies immuno-inflammatoires (P2I)amene a les considerer de facon globale.Ce
Autor:
Christophe Cans, Mallory Perrin-Wolff
Publikováno v:
médecine/sciences. 25:1193-1196
Les anticorps monoclonaux (Acm) therapeutiques sont, depuis quelques annees, identifies par l’industrie pharmaceutique comme l’une des voies therapeutiques les plus prometteuses, temoin d’une nouvelle ere industrielle, celle des biotherapies. L
Autor:
Giulio Superti-Furga, Christophe Cans, Emma Sandilands, George C. Prendergast, Jim C. Norman, Harry Mellor, Valerie G. Brunton, Valerie J. Fincham, Margaret C. Frame
Publikováno v:
Developmental Cell. 7(6):855-869
We have used a c-Src-GFP fusion protein to address the spatial control of Src activation and the nature of Src-associated intracellular structures during stimulus-induced transit to the membrane. Src is activated during transit, particularly in RhoB-
Autor:
Christophe Cans, Nathalie Amzallag, Manuela Argentini, Adam Telerman, David Allanic, Dino Moras, V. F. Shalak, Marc Mirande, Bruno Goud, Virginie Crible, Giusy Fiucci, Vanessa Nancy-Portebois, Brent Passer, Robert Amson, Rowena Tufino
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America
Proceedings of the National Academy of Sciences of the United States of America, 2011, 100 (24), pp.13892-13897. ⟨10.1073/pnas.2335950100⟩
Proceedings of the National Academy of Sciences of the United States of America, National Academy of Sciences, 2011, 100 (24), pp.13892-13897. ⟨10.1073/pnas.2335950100⟩
Proceedings of the National Academy of Sciences of the United States of America, 2011, 100 (24), pp.13892-13897. ⟨10.1073/pnas.2335950100⟩
Proceedings of the National Academy of Sciences of the United States of America, National Academy of Sciences, 2011, 100 (24), pp.13892-13897. ⟨10.1073/pnas.2335950100⟩
Recently, we demonstrated that the expression levels of the translationally controlled tumor protein (TCTP) were strongly down-regulated at the mRNA and protein levels during tumor reversion/suppression and by the activation of p53 and Siah-1. To bet
Autor:
Jean-Michel, Joubert, Jacques-Eric, Gottenberg, Gilles, Paintaud, Béatrice, Augendre-Ferrante, Christophe, Cans, Dominique, Cellier, Marie-Pierre, Chevalier, Isabelle, Diaz, Jamila, Filipecki, Jean-Emmanuel, Kahn, Johan, Le Men, Denis, Mulleman, Rémi, Urbain, Daniel, Vasmant
Publikováno v:
Therapie. 69(4)
Publikováno v:
Molecular Biology Reports. 26:53-57
The CDC25 dual specificity phosphatase is a universal cell cycle regulator. The evolutionary conservation of this enzyme from yeast to man bears witness to its major role in the control of cyclin-dependent kinases (CDK) activity that are central regu
Publikováno v:
Oncogene
Oncogene, Nature Publishing Group, 1997, 14 (20), pp.2485-2495. ⟨10.1038/sj.onc.1201063⟩
Oncogene, Nature Publishing Group, 1997, 14 (20), pp.2485-2495. ⟨10.1038/sj.onc.1201063⟩
CDC25B2, a protein tyrosine phosphatase closely related to the putative CDC25B oncogene, was identified in a Burkitt lymphoma cDNA library. CDC25B2 differs from CDC25B by a 14 residue insertion and a 41 residue deletion, which are both located in the
Publikováno v:
Medecine sciences : M/S. 25(12)
Autor:
Robert Amson, Véronique Bouvard, Marcel Tuynder, Stephanie Morchoisne, Christophe Cans, Aude Roborel de Climens, Sylvie Prieur, Vanessa Nancy-Portebois, Laurent Susini, Brent Passer, Nathalie Amzallag, Giusy Fiucci, Virginie Crible, Adam Telerman, Jean Dausset, Alexandra Lespagnol, Moshe Oren
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America
Proceedings of the National Academy of Sciences of the United States of America, 2003, 100 (5), pp.2284-2289. ⟨10.1073/pnas.0530298100⟩
Proceedings of the National Academy of Sciences of the United States of America, National Academy of Sciences, 2003, 100 (5), pp.2284-2289. ⟨10.1073/pnas.0530298100⟩
Proceedings of the National Academy of Sciences of the United States of America, 2003, 100 (5), pp.2284-2289. ⟨10.1073/pnas.0530298100⟩
Proceedings of the National Academy of Sciences of the United States of America, National Academy of Sciences, 2003, 100 (5), pp.2284-2289. ⟨10.1073/pnas.0530298100⟩
The p53 tumor suppressor protein plays a crucial role in tumorigenesis by controlling cell-cycle progression and apoptosis. We have previously described a transcript designated tumor suppressor activated pathway-6 (TSAP6) that is up-regulated in the